Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474).
Saved in:
| Title: | Accelerating Prostate Stereotactic Ablative Body Radiotherapy (SABR): Efficacy and Toxicity of a Randomized Phase II Study of 11 Versus 29 Days Overall Treatment Time (PATRIOT Study; ClinicalTrials.gov NCT01423474). |
|---|---|
| Authors: | Loblaw, D.A.1 (AUTHOR), Quon, H.C.2 (AUTHOR), Ong, A.T.3 (AUTHOR), Alayed, Y.4 (AUTHOR), Cheung, P.5 (AUTHOR), Chu, W.6 (AUTHOR), Chung, H.T.5 (AUTHOR), Vesprini, D.5 (AUTHOR), Chowdhury, A.3 (AUTHOR), Panjwani, D.7 (AUTHOR), Pang, G.6 (AUTHOR), Korol, R.5 (AUTHOR), Davidson, M.T.8 (AUTHOR), Ravi, A.9 (AUTHOR), McCurdy, B.10 (AUTHOR), Zhang, L.11 (AUTHOR), Mamedov, A.11 (AUTHOR), Deabreu, A.6 (AUTHOR) |
| Source: | International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pS56-S56. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03603016 |
|---|---|
| DOI: | 10.1016/j.ijrobp.2019.06.491 |
